|
1
|
Rezaie T, Child A, Hitchings R, Brice G,
Miller L, Coca-Prados M, Héon E, Krupin T, Ritch R, Kreutzer D, et
al: Adult-onset primary open-angle glaucoma caused by mutations in
optineurin. Science. 295:1077–1079. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Xiao Z, Meng Q, Tsai JC, Yuan H, Xu N and
Li Y: A novel optineurin genetic mutation associated with
open-angle glaucoma in a Chinese family. Mol Vis. 15:1649–1654.
2009.PubMed/NCBI
|
|
3
|
Aung T, Rezaie T, Okada K, Viswanathan AC,
Child AH, Brice G, Bhattacharya SS, Lehmann OJ, Sarfarazi M and
Hitchings RA: Clinical features and course of patients with
glaucoma with the E50K mutation in the optineurin gene. Invest
Ophthalmol Vis Sci. 46:2816–2822. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Leung YF, Fan BJ, Lam DS, Lee WS, Tam PO,
Chua JK, Tham CC, Lai JS, Fan DS and Pang CP: Different optineurin
mutation pattern in primary open-angle glaucoma. Invest Ophthalmol
Vis Sci. 44:3880–3884. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fuse N, Takahashi K, Akiyama H, Nakazawa
T, Seimiya M, Kuwahara S and Tamai M: Molecular genetic analysis of
optineurin gene for primary open-angle and normal tension glaucoma
in the Japanese population. J Glaucoma. 13:299–303. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Alward WL, Kwon YH, Kawase K, Craig JE,
Hayreh SS, Johnson AT, Khanna CL, Yamamoto T, Mackey DA, Roos BR,
et al: Evaluation of optineurin sequence variations in 1,048
patients with open-angle glaucoma. Am J Ophthalmol. 136:904–910.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chalasani ML, Swarup G and Balasubramanian
D: Optineurin and its mutants: Molecules associated with some forms
of glaucoma. Ophthalmic Res. 42:176–184. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chi ZL, Akahori M, Obazawa M, Minami M,
Noda T, Nakaya N, Tomarev S, Kawase K, Yamamoto T, Noda S, et al:
Overexpression of optineurin E50K disrupts Rab8 interaction and
leads to a progressive retinal degeneration in mice. Hum Mol Genet.
19:2606–2615. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wu J and Xie X: Comparative sequence
analysis reveals an intricate network among REST, CREB and miRNA in
mediating neuronal gene expression. Genome Bio. 7:R852006.
View Article : Google Scholar
|
|
10
|
Koch JM, Hinze-Selch D, Stingele K,
Huchzermeier C, Goder R, Seeck-Hirschner M and Aldenhoff JB:
Changes in CREB phosphorylation and BDNF plasma levels during
psychotherapy of depression. Psychother Psychosom. 78:187–192.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fujino H, Kitaoka Y, Hayashi Y, Munemasa
Y, Takeda H, Kumai T, Kobayashi S and Ueno S: Axonal protection by
brain-derived neurotrophic factor associated with CREB
phosphorylation in tumor necrosis factor-alpha-induced optic nerve
degeneration. Acta Neuropathol. 117:75–84. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nakatani M, Shinohara Y, Takii M, Mori H,
Asai N, Nishimura S, Furukawa-Hibi Y, Miyamoto Y and Nitta A:
Periocular injection of in situ hydrogels containing Leu-Ile, an
inducer for neurotrophic factors, promotes retinal ganglion cell
survival after optic nerve injury. Exp Eye Res. 93:873–879. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ambros V: microRNAs: Tiny regulators with
great potential. Cell. 107:823–826. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xiao F, Zuo Z, Cai G, Kang S, Gao X and Li
T: miRecords: An integrated resource for microRNA-target
interactions. Nucleic Acids Res. 37:(Database issue). D105–D110.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jiang Q, Wang Y, Hao Y, Juan L, Teng M,
Zhang X, Li M, Wang G and Liu Y: miR2 Disease: A manually curated
database for microRNA deregulation in human disease. Nucleic Acids
Res. 37:(Database issue). D98–D104. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Friedman RC, Farh KK, Burge CB and Bartel
DP: Most mammalian mRNAs are conserved targets of microRNAs. Genome
Res. 19:92–105. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Packer AN, Xing Y, Harper SQ, Jones L and
Davidson BL: The bifunctional microRNA miR-9/miR-9* regulates REST
and CoREST and is downregulated in Huntington's disease. J
Neurosci. 28:14341–14346. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang B, Shan L, Song W, Xiao Z, Shi L and
Yuan H: Copolymer-1 immunization reduces damage in retinal ganglion
cells under high intraocular pressure through altering the
expression of retinal neurotrophins. J Ocul Pharmacol Ther.
26:11–19. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Leucht C, Stigloher C, Wizenmann A, Klafke
R, Folchert A and Bally-Cuif L: MicroRNA-9 directs late organizer
activity of the midbrain-hindbrain boundary. Nat Neurosci.
11:641–648. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Oshitari T and Adachi-Usami E: The effect
of caspase inhibitors and neurotrophic factors on damaged retinal
ganglion cells. Neuroreport. 14:289–292. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nowak A, Majsterek I, Przybyłowska-Sygut
K, Pytel D, Szymanek K, Szaflik J and Szaflik JP: Analysis of the
expression and polymorphism of APOE, HSP, BDNF, and GRIN2B genes
associated with the neurodegeneration process in the pathogenesis
of primary open angle glaucoma. Biomed Res Int. 2015:2582812015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gupta V, You Y, Li J, Golzan M, Klistorner
A, van den Buuse M and Graham S: BDNF impairment is associated with
age-related changes in the inner retina and exacerbates
experimental glaucoma. Biochim Biophys Acta. 1842:1567–1578. 2014.
View Article : Google Scholar : PubMed/NCBI
|
